Nanomol Technologies S.L.

Nanomol Technologies is both a drug delivery and cGMP contract analysis partner for pharmaceutical and biotech industries. Its DELOS nanoformulation platform enables the development of high-added-value medicines with enhanced efficacy, selectivity and reduced side effects, and the company provides expert characterization of critical quality attributes such as particle size, morphology, and solid-state/colloidal-state properties of drug substances and drug products.